← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Clarivate Plc (CLVT) 10-Year Financial Performance & Capital Metrics

CLVT • • Industrial / General
TechnologyIT ServicesResearch & Advisory ServicesTechnology Research & Intelligence
AboutClarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.Show more
  • Revenue $2.56B -2.7%
  • EBITDA $451M +1809.8%
  • Net Income -$637M +30.1%
  • EPS (Diluted) -0.96 +34.7%
  • Gross Margin 66% +0.7%
  • EBITDA Margin 17.66% +1858.0%
  • Operating Margin -10.78% +61.4%
  • Net Margin -24.9% +28.2%
  • ROE -11.44% +19.6%
  • ROIC -2.08% +58.5%
  • Debt/Equity 0.89 +11.4%
  • Interest Coverage -0.97 +61.1%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 21.3%
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗Weak momentum: RS Rating 18 (bottom 18%)
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y21.28%
3Y10.85%
TTM-2.96%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM69.27%

EPS CAGR

10Y-
5Y-
3Y-
TTM70.37%

ROCE

10Y Avg-5.73%
5Y Avg-7.09%
3Y Avg-11.49%
Latest-2.6%

Peer Comparison

Technology Research & Intelligence
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
IIIInformation Services Group, Inc.291.14M6.08101.33-14.94%4.05%10.32%5.85%0.67
HCKTThe Hackett Group, Inc.511.77M20.3919.425.82%3.54%10.74%8.53%0.14
ITGartner, Inc.16.61B230.3814.406.1%13.71%159.13%8.33%2.13
NOTEFiscalNote Holdings, Inc.24.78M1.651.99-9.33%-54.31%-73.85%1.77
CLVTClarivate Plc2.13B3.22-3.35-2.74%-15.83%-8.08%16.79%0.89
NIQNIQ Global Intelligence Plc5.16B17.49-5.2818.89%-11.24%-106.47%8.89

Profit & Loss

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+917.63M968.47M974.35M1.25B1.88B2.66B2.63B2.56B
Revenue Growth %-0.06%0.01%0.29%0.5%0.42%-0.01%-0.03%
Cost of Goods Sold+394.21M396.5M352M438.8M626.1M954M906.4M869.2M
COGS % of Revenue0.43%0.41%0.36%0.35%0.33%0.36%0.34%0.34%
Gross Profit+523.42M571.97M622.35M815.3M1.25B1.71B1.72B1.69B
Gross Margin %0.57%0.59%0.64%0.65%0.67%0.64%0.66%0.66%
Gross Profit Growth %-0.09%0.09%0.31%0.53%0.36%0.01%-0.02%
Operating Expenses+589.51M613.94M704.83M851.6M1.34B5.63B2.46B1.96B
OpEx % of Revenue0.64%0.63%0.72%0.68%0.71%2.12%0.93%0.77%
Selling, General & Admin360.81M383.09M475.01M544.7M643M729.9M739.7M727.6M
SG&A % of Revenue0.39%0.4%0.49%0.43%0.34%0.27%0.28%0.28%
Research & Development00000000
R&D % of Revenue--------
Other Operating Expenses0230.85M229.82M306.9M694.8M4.9B1.72B1.24B
Operating Income+-147.03M-105.71M-82.49M-36.3M-87M-3.93B-734.7M-275.6M
Operating Margin %-0.16%-0.11%-0.08%-0.03%-0.05%-1.48%-0.28%-0.11%
Operating Income Growth %-0.28%0.22%0.56%-1.4%-44.12%0.81%0.62%
EBITDA+81.44M131.52M118.06M266.9M450.8M-3.22B-26.4M451.4M
EBITDA Margin %0.09%0.14%0.12%0.21%0.24%-1.21%-0.01%0.18%
EBITDA Growth %-0.61%-0.1%1.26%0.69%-8.13%0.99%18.1%
D&A (Non-Cash Add-back)228.46M237.22M200.54M303.2M537.8M710.5M708.3M727M
EBIT-147.03M-105.71M-90.74M-241.4M-5.7M-3.72B-718.8M-270.4M
Net Interest Income+-138.2M-130.81M-157.69M-111.9M-252.5M-270.3M-293.7M-283.4M
Interest Income00000000
Interest Expense138.2M130.81M157.69M111.9M252.5M270.3M293.7M283.4M
Other Income/Expense-138.2M-130.81M-165.95M-317M-171.2M-63.5M-277.8M-278.2M
Pretax Income+-285.22M-236.51M-248.43M-353.3M-258.2M-3.99B-1.01B-553.8M
Pretax Margin %-0.31%-0.24%-0.25%-0.28%-0.14%-1.5%-0.39%-0.22%
Income Tax+-21.29M5.65M10.2M-2.7M12.3M-28.9M-101.3M82.9M
Effective Tax Rate %0.93%1.02%1.04%0.99%1.05%0.99%0.9%1.15%
Net Income+-263.93M-242.16M-258.63M-350.6M-270.5M-3.96B-911.2M-636.7M
Net Margin %-0.29%-0.25%-0.27%-0.28%-0.14%-1.49%-0.35%-0.25%
Net Income Growth %-0.08%-0.07%-0.36%0.23%-13.64%0.77%0.3%
Net Income (Continuing)-263.93M-242.16M-258.63M-350.6M-270.5M-3.96B-911.2M-636.7M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)+-0.86-0.79-0.39-0.63-0.61-6.24-1.47-0.96
EPS Growth %-0.08%0.51%-0.62%0.03%-9.23%0.76%0.35%
EPS (Basic)-0.86-0.79-0.39-0.63-0.62-6.26-1.47-0.96
Diluted Shares Outstanding305.25M305.25M273.88M428.6M640.77M678.6M671.6M693.6M
Basic Shares Outstanding305.25M305.25M273.88M428.6M630.98M676.1M671.6M693.6M
Dividend Payout Ratio--------

Balance Sheet

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+443.91M408.61M493.08M1.15B1.64B1.4B1.46B1.24B
Cash & Short-Term Investments53.19M25.57M76.13M257.73M587.61M348.8M370.7M295.2M
Cash Only53.19M25.57M76.13M257.73M587.61M348.8M370.7M295.2M
Short-Term Investments00000000
Accounts Receivable317.81M331.3M333.86M737.73M906.43M872.1M908.3M798.3M
Days Sales Outstanding126.41124.86125.07214.71176.27119.68126.11113.97
Inventory52.76M31.03M00097.4M00
Days Inventory Outstanding48.8528.56---37.27--
Other Current Assets44.52M31.13M42.38M93.83M66.65M76.9M94.7M65.2M
Total Non-Current Assets+3.56B3.3B3.3B13.64B18.55B12.55B11.24B10.25B
Property, Plant & Equipment23.01M20.64M103.49M168.62M169.88M113.4M106.8M107.1M
Fixed Asset Turnover39.88x46.92x9.41x7.44x11.05x23.46x24.61x23.87x
Goodwill1.31B1.28B1.33B6.04B7.9B2.88B2.02B1.57B
Intangible Assets2.16B1.96B1.83B7.37B10.39B9.44B9.01B8.44B
Long-Term Investments00001.96M47.2M17.7M14.7M
Other Non-Current Assets60.03M26.56M18.63M31.33M48.75M50.7M43.1M67.5M
Total Assets+4.01B3.71B3.79B14.79B20.18B13.94B12.71B11.49B
Asset Turnover0.23x0.26x0.26x0.08x0.09x0.19x0.21x0.22x
Asset Growth %--0.07%0.02%2.9%0.36%-0.31%-0.09%-0.1%
Total Current Liabilities+661.07M643.71M651M1.42B1.9B1.56B1.6B1.43B
Accounts Payable60.76M38.42M26.46M82.04M129.22M101.4M144.1M124.5M
Days Payables Outstanding56.2635.3727.4468.2475.3338.858.0352.28
Short-Term Debt45.34M60.34M9M28.6M62.75M26.7M24.4M20.6M
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities0026.87M57.75M348.01M326.4M321.9M-20.6M
Current Ratio0.67x0.63x0.76x0.81x0.86x0.89x0.91x0.87x
Quick Ratio0.59x0.59x0.76x0.81x0.86x0.83x0.91x0.87x
Cash Conversion Cycle119118.06---118.15--
Total Non-Current Liabilities+2.06B2.02B1.89B4.33B6.36B5.57B5.11B4.92B
Long-Term Debt1.97B1.93B1.63B3.46B5.46B4.97B4.72B4.52B
Capital Lease Obligations0064.19M104.32M93.95M72.9M63.2M53.2M
Deferred Tax Liabilities51.79M43.23M48.55M367M380.06M316.1M249.6M273.3M
Other Non-Current Liabilities22.61M24.84M130.7M362.2M370.59M171.4M41.9M55.9M
Total Liabilities2.72B2.66B2.54B5.76B8.26B7.13B6.71B6.35B
Total Debt+2.01B1.99B1.72B3.63B5.61B5.1B4.81B4.59B
Net Debt1.96B1.96B1.65B3.37B5.03B4.76B4.44B4.3B
Debt / Equity1.57x1.89x1.38x0.40x0.47x0.75x0.80x0.89x
Debt / EBITDA24.72x15.14x14.60x13.59x12.45x--10.17x
Net Debt / EBITDA24.07x14.94x13.96x12.62x11.15x--9.52x
Interest Coverage-1.06x-0.81x-0.52x-0.32x-0.34x-14.52x-2.50x-0.97x
Total Equity+1.29B1.05B1.25B9.03B11.93B6.81B5.99B5.14B
Equity Growth %--0.18%0.19%6.24%0.32%-0.43%-0.12%-0.14%
Book Value per Share4.213.444.5621.0818.6110.048.927.41
Total Shareholders' Equity1.29B1.05B1.25B9.03B11.93B6.81B5.99B5.14B
Common Stock16K16K2.14B9.99B11.83B11.74B11.74B12.98B
Retained Earnings-390.1M-632.26M-890.89M-1.25B-1.6B-5.66B-6.65B-7.31B
Treasury Stock000-196.04M-16.96M000
Accumulated OCI13.98M5.36M-4.88M492.38M326.75M-665.9M-495.3M-526.3M
Minority Interest00000000

Cash Flow

Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+6.67M-26.1M117.58M263.5M323.8M509.3M744.2M646.6M
Operating CF Margin %0.01%-0.03%0.12%0.21%0.17%0.19%0.28%0.25%
Operating CF Growth %--4.91%5.5%1.24%0.23%0.57%0.46%-0.13%
Net Income-263.93M-242.16M-258.63M-350.6M-270.5M-3.96B-911.2M-636.7M
Depreciation & Amortization228.46M237.22M200.54M303.2M537.8M710.5M708.3M727M
Stock-Based Compensation17.66M13.71M034.2M33.3M93.9M109M59.9M
Deferred Taxes-36.27M19.72M357K-45.5M-13.3M-54.3M-78.4M21.2M
Other Non-Cash Items32.56M-27.39M171.6M215.1M-31.5M3.99B976.9M500.1M
Working Capital Changes28.18M-27.2M3.71M107.1M68M-271.9M-60.4M-24.9M
Change in Receivables43.11M-50.91M-593K29.9M-64.1M-28.3M-25.5M92.6M
Change in Inventory5.98M8.26M000000
Change in Payables-39.66M-18.09M-13.84M-2.9M31.2M-24M41.2M-15M
Cash from Investing+-40.2M11.93M-140.88M-2.99B-4.04B57.3M-237.4M-236.7M
Capital Expenditures-37.8M-45.41M-72.46M-107.7M-118.5M-202.9M-242.5M-289.1M
CapEx % of Revenue0.04%0.05%0.07%0.09%0.06%0.08%0.09%0.11%
Acquisitions--------
Investments--------
Other Investing5M80.88M0000084.4M
Cash from Financing+22.82M-32.6M75.22M2.93B4.03B-759.2M-496.5M-470.1M
Debt Issued (Net)--------
Equity Issued (Net)--------
Dividends Paid0000-18.9M-75.4M-75.5M-37.7M
Share Repurchases--------
Other Financing8.24M-896K479.72M200.5M-38.8M-12.3M-20.5M-34.3M
Net Change in Cash--------
Free Cash Flow+-31.14M-71.51M47.74M155.8M205.3M306.4M501.7M357.5M
FCF Margin %-0.03%-0.07%0.05%0.12%0.11%0.12%0.19%0.14%
FCF Growth %--1.3%1.67%2.26%0.32%0.49%0.64%-0.29%
FCF per Share-0.10-0.230.170.360.320.450.750.52
FCF Conversion (FCF/Net Income)-0.03x0.11x-0.45x-0.75x-1.20x-0.13x-0.82x-1.02x
Interest Paid115.24M121.92M097.5M182.4M251.5M273.5M265.3M
Taxes Paid14.72M13.21M027.6M33.9M63.7M42.9M52.9M

Key Ratios

Metric20172018201920202021202220232024
Return on Equity (ROE)-20.52%-20.73%-22.5%-6.82%-2.58%-42.27%-14.23%-11.44%
Return on Invested Capital (ROIC)-3.4%-2.53%-2.09%-0.36%-0.44%-20.65%-5.01%-2.08%
Gross Margin57.04%59.06%63.87%65.01%66.64%64.13%65.52%66%
Net Margin-28.76%-25%-26.54%-27.96%-14.41%-148.89%-34.66%-24.9%
Debt / Equity1.57x1.89x1.38x0.40x0.47x0.75x0.80x0.89x
Interest Coverage-1.06x-0.81x-0.52x-0.32x-0.34x-14.52x-2.50x-0.97x
FCF Conversion-0.03x0.11x-0.45x-0.75x-1.20x-0.13x-0.82x-1.02x
Revenue Growth-5.54%0.61%28.71%49.66%41.71%-1.17%-2.74%

Revenue by Segment

201920202021202220232024
Subscription Revenues-867.73M1.03B1.62B1.62B1.63B
Subscription Revenues Growth--19.20%56.60%-0.10%0.54%
Transaction Revenues-294.89M393.25M599.1M566.1M500.1M
Transaction Revenues Growth--33.35%52.35%-5.51%-11.66%
Re-occurring Revenues-114.53M453.24M441.9M444.6M429.8M
Re-occurring Revenues Growth--295.75%-2.50%0.61%-3.33%
Science Group547.54M-----
Science Group Growth------
Intellectual Property Group427.24M-----
Intellectual Property Group Growth------
Web Of Science Product Line380.3M-----
Web Of Science Product Line Growth------
Derwent Product Line181.95M-----
Derwent Product Line Growth------
Life Sciences Product Line167.24M-----
Life Sciences Product Line Growth------
Markmonitor Product Line122.84M-----
Markmonitor Product Line Growth------
Compumark Product Line122.45M-----
Compumark Product Line Growth------
Ip Management Product Line------
Ip Management Product Line Growth------

Revenue by Geography

201920202021202220232024
North America-631.22M928.69M1.46B1.41B1.38B
North America Growth--47.13%57.60%-3.97%-1.71%
EMEA-365.6M555.8M698.1M707.5M667.8M
EMEA Growth--52.03%25.60%1.35%-5.61%
Asia Pacific233M280.33M396.35M499.1M515.8M507.5M
Asia Pacific Growth-20.31%41.39%25.92%3.35%-1.61%
Americas463.04M-----
Americas Growth------
Europe278.74M-----
Europe Growth------

Frequently Asked Questions

Growth & Financials

Clarivate Plc (CLVT) reported $2.50B in revenue for fiscal year 2024. This represents a 173% increase from $917.6M in 2017.

Clarivate Plc (CLVT) saw revenue decline by 2.7% over the past year.

Clarivate Plc (CLVT) reported a net loss of $396.0M for fiscal year 2024.

Dividend & Returns

Yes, Clarivate Plc (CLVT) pays a dividend with a yield of 1.69%. This makes it attractive for income-focused investors.

Clarivate Plc (CLVT) has a return on equity (ROE) of -11.4%. Negative ROE indicates the company is unprofitable.

Clarivate Plc (CLVT) generated $335.2M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.